NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 3 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $256,000 | -20.5% | 18,000 | -23.1% | 0.00% | – |
| Q1 2016 | $322,000 | +33.6% | 23,400 | +63.6% | 0.00% | – |
| Q4 2015 | $241,000 | +97.5% | 14,300 | +28.8% | 0.00% | – |
| Q3 2015 | $122,000 | -37.4% | 11,100 | -28.8% | 0.00% | – |
| Q2 2015 | $195,000 | -31.1% | 15,600 | -39.3% | 0.00% | – |
| Q1 2015 | $283,000 | +45.9% | 25,700 | +105.6% | 0.00% | – |
| Q4 2014 | $194,000 | -15.3% | 12,500 | -34.2% | 0.00% | – |
| Q3 2014 | $229,000 | +59.0% | 19,000 | +69.6% | 0.00% | – |
| Q2 2014 | $144,000 | -18.2% | 11,200 | -22.8% | 0.00% | – |
| Q1 2014 | $176,000 | -7.4% | 14,500 | -13.2% | 0.00% | – |
| Q4 2013 | $190,000 | -54.4% | 16,700 | -58.1% | 0.00% | -100.0% |
| Q3 2013 | $417,000 | +231.0% | 39,900 | +266.1% | 0.00% | – |
| Q2 2013 | $126,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 237 | $103,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 35,300 | $595,000 | 0.01% |
| Citadel Advisors | 14,300 | $241,000 | 0.00% |